Clinical Trial Update: A Feasibility Study: Assessing Photobiomodulation in Myalgic Encephalomyelitis [NA]

View source ↗

Summary

A feasibility study evaluating photobiomodulation for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Myalgic Encephalomyelitis

Snippet

Sponsor: Quadram Institute Bioscience | Conditions: Myalgic Encephalomyelitis, Chronic Fatigue Syndrome | NA | Status: ENROLLING_BY_INVITATION